
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Document Content</title>
    <style>
        body { font-family: Arial, sans-serif; line-height: 1.6; max-width: 900px; margin: auto; padding: 20px; }
        table { border-collapse: collapse; width: 100%; margin-top: 20px; margin-bottom: 20px; }
        th, td { border: 1px solid #cccccc; text-align: left; padding: 8px; font-size: 12px; }
        tr:nth-child(even) { background-color: #f9f9f9; }
        th { background-color: #3366CC; color: white; font-weight: bold; }
        h2 { color: #4F81BD; border-bottom: 2px solid #4F81BD; padding-bottom: 5px;}
        p { margin-block-start: 0.5em; margin-block-end: 0.5em; }
    </style>
</head>
<body>
    <p style="font-size: small; color: grey;"><i>z_PAI Europe VI_2017Q4 FS-PTF_083.pdf</i></p>
<p>confidential Info&amp;Record Team ARDIAN 08 mars 2018 02:25</p>
<p>VI</p>
<h2>Assets</h2>

<table>
	<tr>
		<th><sup>As</sup> of 31 December 2017</th>
		<th>Investment date</th>
		<th>Investment cost</th>
		<th>Realised proceeds</th>
		<th>Cost of remaining assets</th>
		<th>Unrealised value</th>
		<th>Total value</th>
	</tr>
	<tr>
		<td>Current portfolio</td>
		<td></td>
		<td></td>
		<td>I</td>
		<td></td>
		<td>II</td>
		<td>I + II</td>
	</tr>
	<tr>
		<td>EMG</td>
		<td>Jul. 2014</td>
		<td>74.9</td>
		<td>–</td>
		<td>74.9</td>
		<td>134.2</td>
		<td>134.2</td>
	</tr>
	<tr>
		<td>Labeyrie <sup>1</sup></td>
		<td>Jul. 2014</td>
		<td>93.1</td>
		<td>60.6</td>
		<td>46.8</td>
		<td>137.6</td>
		<td>198.2</td>
	</tr>
	<tr>
		<td>VPS <sup>2</sup></td>
		<td>Jul. 2014</td>
		<td>153.1</td>
		<td>–</td>
		<td>153.1</td>
		<td>0.0</td>
		<td>0.0</td>
	</tr>
	<tr>
		<td>InnoVista Sensors</td>
		<td>Sep. 2014</td>
		<td>85.7</td>
		<td>161.3</td>
		<td>12.7</td>
		<td>36.7</td>
		<td>198.0</td>
	</tr>
	<tr>
		<td>AS Adventure <sup>3</sup></td>
		<td>Apr. 2015</td>
		<td>240.1</td>
		<td>–</td>
		<td>240.1</td>
		<td>240.0</td>
		<td>240.0</td>
	</tr>
	<tr>
		<td>Konecta</td>
		<td>Dec. 2015</td>
		<td>89.7</td>
		<td>–</td>
		<td>89.7</td>
		<td>157.8</td>
		<td>157.8</td>
	</tr>
	<tr>
		<td>B&amp;B Hotels</td>
		<td>Mar. 2016</td>
		<td>234.8</td>
		<td>–</td>
		<td>234.8</td>
		<td>371.9</td>
		<td>371.9</td>
	</tr>
	<tr>
		<td>Atos Medical</td>
		<td>Jul. 2016</td>
		<td>203.5</td>
		<td>–</td>
		<td>203.5</td>
		<td>241.5</td>
		<td>241.5</td>
	</tr>
	<tr>
		<td>Ethypharm <sup>4</sup></td>
		<td>Jul. 2016</td>
		<td>240.2</td>
		<td>–</td>
		<td>240.2</td>
		<td>265.5</td>
		<td>265.5</td>
	</tr>
	<tr>
		<td>Roompot</td>
		<td>Nov. 2016</td>
		<td>162.4</td>
		<td>–</td>
		<td>162.4</td>
		<td>252.2</td>
		<td>252.2</td>
	</tr>
	<tr>
		<td>ELITech <sup>5</sup></td>
		<td>Jul. 2017</td>
		<td>196.0</td>
		<td>–</td>
		<td>196.0</td>
		<td>198.5</td>
		<td>198.5</td>
	</tr>
	<tr>
		<td>Cortefiel <sup>6</sup></td>
		<td>Sep. 2017</td>
		<td>100.7</td>
		<td>–</td>
		<td>100.7</td>
		<td>102.5</td>
		<td>102.5</td>
	</tr>
	<tr>
		<td>Realised investment</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>DomusVi</td>
		<td>Sep. 2014</td>
		<td>167.2</td>
		<td>546.8</td>
		<td>-</td>
		<td>–</td>
		<td>546.8</td>
	</tr>
	<tr>
		<td>Total investment portfolio</td>
		<td></td>
		<td>2,041.4</td>
		<td>768.7</td>
		<td>1,754.9</td>
		<td>2,138.4</td>
		<td>2,907.1</td>
	</tr>
	<tr>
		<td>Cash available</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td>40.8</td>
		<td></td>
	</tr>
	<tr>
		<td>Other assets and liabilities</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
		<td>(3.2)</td>
		<td></td>
	</tr>
	<tr>
		<td colspan="2">Equity bridge financing facility <sup>1,2,3,4,5,6</sup></td>
		<td></td>
		<td></td>
		<td></td>
		<td>(347.4)</td>
		<td></td>
	</tr>
	<tr>
		<td colspan="2">Total net assets (LPs and GP)</td>
		<td></td>
		<td></td>
		<td></td>
		<td>1,828.6</td>
		<td></td>
	</tr>
</table>
<p>1. An add-on in Labeyrie was fully financed using PAI Europe VI&#x27;s equity bridge financing facility for €4.5 million</p>
<p>2. An add-on in VPS was fully financed using PAI Europe VI&#x27;s equity bridge financing facility for €14.0 million</p>
<p>3. An add-on in AS Adventure was fully financed using PAI Europe VI&#x27;s equity bridge financing facility for €20.2 million</p>
<p>4. An add-on in Ethypharm was fully financed using PAI Europe VI&#x27;s equity bridge financing facility for €12.0 million</p>
<p>5. ELITech was fully financed using PAI Europe VI&#x27;s equity bridge financing facility for €196.0 million</p>
<p>6. Cortefiel was fully financed using PAI Europe VI&#x27;s equity bridge financing facility for €100.7 million</p>
<p style="font-size: small; color: grey;"><i>PAI Europe VI 31 December 2017 Private and confidential</i></p>
<p style="font-size: small; color: grey;"><i>83</i></p>
<p><sup>confidential</sup> 83 Info&amp;Record Team ARDIAN 08 mars 2018, 02:25</p>

</body>
</html>
